Tenofovir Alafenamide 25mgTablet
Hepatology & Liver Care

Tenofovir Alafenamide 25mg

Tenofovir Alafenamide

Next-generation tenofovir prodrug with targeted hepatic delivery providing equivalent HBV suppression at 1/10th the dose of TDF with significantly less bone and renal toxicity. Manufactured by Cipla and Hetero for hepatology export.

Strengths

25mg

Packing

30 tablets/bottle

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Tenofovir Alafenamide (TAF) 25mg
Dosage Form
Tablet
Available Strengths
25mg
Packing
30 tablets/bottle
Route of Administration
Oral, with food
Dosage
25mg once daily with food
Indications
Chronic hepatitis B with compensated liver disease, HBV with renal impairment or osteoporosis
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, protect from moisture
Shelf Life
36 months
Side Effects
Headache, abdominal pain, fatigue, cough, nausea, back pain
Precautions
HBV flare on discontinuation — monitor LFTs for months after stopping; no dose adjustment in renal impairment; less nephrotoxic and bone-sparing vs TDF; take with food for adequate absorption

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Need bulk pricing for Tenofovir Alafenamide 25mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote